SPC Logo

Fosamax

Last Updated on eMC 12-Dec-2014 View document  | Merck Sharp & Dohme Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12-Dec-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Updated on 12-Nov-2012 and displayed until 12-Dec-2014

Reasons for adding or updating:

  • Change to side-effects

Updated on 22-Dec-2011 and displayed until 12-Nov-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to drug interactions

Updated on 11-Nov-2011 and displayed until 22-Dec-2011

Reasons for adding or updating:

  • Change to side-effects

Updated on 04-Apr-2011 and displayed until 11-Nov-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects

Updated on 30-Mar-2010 and displayed until 04-Apr-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to dosage and administration

Updated on 08-Aug-2008 and displayed until 30-Mar-2010

Reasons for adding or updating:

  • Change to side-effects
  • Change due to user-testing of patient information

Updated on 05-Mar-2007 and displayed until 08-Aug-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 23-Jan-2006 and displayed until 05-Mar-2007

Reasons for adding or updating:

  • Change to side-effects

Updated on 06-May-2004 and displayed until 23-Jan-2006

Reasons for adding or updating:

  • Change to side-effects
  • Change to warnings or special precautions for use

Updated on 21-Dec-2001 and displayed until 06-May-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 18-Jul-2001 and displayed until 21-Dec-2001

Reasons for adding or updating:

  • Update to PIL

Updated on 17-Aug-2000 and displayed until 18-Jul-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Merck Sharp & Dohme Limited

Company image
Address

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU

Fax

+44 (0)1992 479 292

Stock Availability

Call MSD customer services on 01992 452094

Telephone

+44 (0)1992 467 272

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

alendronate sodium

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue